Sort   by:  
 Page size 
UnknownProspective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS-wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Final results of the non-interventional study VALIDATE.
Existing prognostic scores for metastatic colorectal cancer (mCRC) are based on randomized clinical trial data and focus on parameters evaluated at the start of first-line (1L) treatment. Unlike these, the modified mCRC prognostic score (mCCS) was developed using real-world data from the German tumo...
S-EPMC12670338 | biostudies-literature
UnknownPrognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.

Introduction

Understanding prognosis, especially long-term outcome, in advanced nonsmall cell lung cancer (NSCLC) is crucial to inform patients, guide treatment and plan supportive and palliative care.

Methods

Prognostic factors influencing overall survival (OS) and progression-free s...
S-EPMC9892864 | biostudies-literature
Sort   by:  
 Page size